: As of the end of March, a total of 81 million yuan worth of shares have been repurchased.

Heavy Medicine Holdings announced that in July 2025, the company passed a proposal to repurchase shares, intending to use 80-100 million yuan of its own funds and special loans to repurchase shares for the purpose of reducing capital. The repurchase price shall not exceed 6.6 yuan per share, with a term of 12 months. As of March 31, 2026, the company has repurchased a total of 15.4066 million shares, accounting for approximately 0.8915% of the total share capital. The highest transaction price was 5.48 yuan per share, the lowest transaction price was 5.01 yuan per share, and the total amount paid was 80.9988 million yuan. Subsequent repurchases will continue to be implemented in accordance with regulations and progress will be disclosed.